BatchLine, who provides digital solutions of groundbreaking cloud EBR that simplify and streamline operations is thrilled to announce that Cyto-Facto, a leading provider in the field of cell and gene therapy is not only our highly valued customer but also our official partnership.
This collaboration marks a significant milestone in advancing the health and well-being of patients who need cutting-edge cell and gene therapies.
This collaboration marks a significant milestone in advancing the health and well-being of patients who need cutting-edge cell and gene therapies.
Â
Â
(Left) Dave Margetts, CEO at BatchLine
(Right) Shin Kawamata, CEO at Cyto Facto
(Right) Shin Kawamata, CEO at Cyto Facto
Â
Â
Further information, please contact us or email directly to info@batchline.com
Â
Â
(Left) David Holt, Managing Director at BatchLine
(Right) Dave Margetts, CEO at BatchLine
(Right) Dave Margetts, CEO at BatchLine
